Incidence of typhoid fever in Burkina Faso, Democratic Republic of the Congo, Ethiopia, Ghana, Madagascar, and Nigeria (the Severe Typhoid in Africa programme): a population-based study.

Autor: Marks F; International Vaccine Institute, Seoul, South Korea; Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK; Heidelberg Institute of Global Health, University of Heidelberg, Heidelberg, Germany; Madagascar Institute for Vaccine Research, University of Antananarivo, Antananarivo, Madagascar. Electronic address: fmarks@ivi.int., Im J; International Vaccine Institute, Seoul, South Korea., Park SE; International Vaccine Institute, Seoul, South Korea; Yonsei University Graduate School of Public Health, Seoul, South Korea; Yonsei University Graduate School of Public Health, Seoul, South Korea., Pak GD; International Vaccine Institute, Seoul, South Korea., Jeon HJ; International Vaccine Institute, Seoul, South Korea; Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK; Madagascar Institute for Vaccine Research, University of Antananarivo, Antananarivo, Madagascar., Wandji Nana LR; Institut Supérieur des Sciences de la Population, Ouagadougou, Burkina Faso., Phoba MF; Department of Microbiology, Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo; Department of Medical Biology, Microbiology Service, University Teaching Hospital of Kinshasa, University of Kinshasa, Kinshasa, Democratic Republic of the Congo., Mbuyi-Kalonji L; Department of Microbiology, Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo; Department of Medical Biology, Microbiology Service, University Teaching Hospital of Kinshasa, University of Kinshasa, Kinshasa, Democratic Republic of the Congo., Mogeni OD; International Vaccine Institute, Seoul, South Korea., Yeshitela B; Armauer Hansen Research Institute, Addis Ababa, Ethiopia., Panzner U; International Vaccine Institute, Seoul, South Korea., Cruz Espinoza LM; International Vaccine Institute, Seoul, South Korea., Beyene T; Armauer Hansen Research Institute, Addis Ababa, Ethiopia., Owusu-Ansah M; School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana., Twumasi-Ankrah S; School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana; Department of Statistics and Actuarial Science, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana., Yeshambaw M; Armauer Hansen Research Institute, Addis Ababa, Ethiopia., Alemu A; Department of Medicine, University of Ibadan, Ibadan, Nigeria., Adewusi OJ; College of Medicine, University of Ibadan, Ibadan, Nigeria., Adekanmbi O; Department of Medicine, University of Ibadan, Ibadan, Nigeria; Department of Community Medicine, University College Hospital, Ibadan, Nigeria., Higginson E; Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK., Adepoju A; Department of Paediatrics, University of Ibadan, Ibadan, Nigeria; Department of Community Medicine, University College Hospital, Ibadan, Nigeria., Agbi S; Department of Medicine, University of Ibadan, Ibadan, Nigeria., Cakpo EG; Institut Supérieur des Sciences de la Population, Ouagadougou, Burkina Faso., Ogunleye VO; Department of Community Medicine, University College Hospital, Ibadan, Nigeria., Tunda GN; Department of Microbiology, Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo; Faculty of Medicine, Congo Protestant University, Kinshasa, Democratic Republic of the Congo., Ikhimiukor OO; Department of Pharmaceutical Microbiology, Faculty of Pharmacy, University of Ibadan, Ibadan, Nigeria., Mbuyamba J; Department of Microbiology, Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo; Department of Medical Biology, Microbiology Service, University Teaching Hospital of Kinshasa, University of Kinshasa, Kinshasa, Democratic Republic of the Congo., Toy T; International Vaccine Institute, Seoul, South Korea., Agyapong FO; Department of Clinical Microbiology, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana., Osei I; Medical Research Council Unit, The Gambia at London School of Hygiene & Tropical Medicine, Banjul, The Gambia; Faculty of Infectious & Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK., Amuasi J; School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana; Bernhard Nocht Institute of Tropical Medicine, Hamburg, Germany; Kumasi Centre for Collaborative Research in Tropical Medicine (KCCR), Kumasi, Ghana., Razafindrabe TJL; Madagascar Institute for Vaccine Research, University of Antananarivo, Antananarivo, Madagascar., Raminosoa TM; Madagascar Institute for Vaccine Research, University of Antananarivo, Antananarivo, Madagascar., Nyirenda G; International Vaccine Institute, Seoul, South Korea., Randriamampionona N; Madagascar Institute for Vaccine Research, University of Antananarivo, Antananarivo, Madagascar., Seo HW; International Vaccine Institute, Seoul, South Korea., Seo H; International Vaccine Institute, Seoul, South Korea., Siribie M; International Vaccine Institute, Seoul, South Korea., Carey ME; Department of Infection Biology, London School of Hygiene & Tropical Medicine, London, UK; International AIDS Vaccine Initiative, Chelsea & Westminster Hospital, London, UK., Owusu M; Department of Medical Diagnostics, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana; Centre for Health System Strengthening (CfHSS), Kumasi, Ghana; Kumasi Centre for Collaborative Research in Tropical Medicine (KCCR), Kumasi, Ghana., Meyer CG; Institute of Tropical Medicine, Eberhard-Karls University Tübingen, Tübingen, Germany; Duy Tan University, Da Nang, Viet Nam., Rakotozandrindrainy N; Madagascar Institute for Vaccine Research, University of Antananarivo, Antananarivo, Madagascar., Sarpong N; School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana., Razafindrakalia M; Madagascar Institute for Vaccine Research, University of Antananarivo, Antananarivo, Madagascar., Razafimanantsoa R; Madagascar Institute for Vaccine Research, University of Antananarivo, Antananarivo, Madagascar., Ouedraogo M; Hôpital Protestant Schiphra, Ouagadougou, Burkina Faso., Kim YJ; International Vaccine Institute, Seoul, South Korea., Lee J; International Vaccine Institute, Seoul, South Korea; Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia., Zellweger RM; International Vaccine Institute, Seoul, South Korea., Kang SSY; International Vaccine Institute, Seoul, South Korea., Park JY; International Vaccine Institute, Seoul, South Korea; Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK., Crump JA; Centre for International Health, University of Otago, Dunedin, New Zealand., Hardy L; Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium., Jacobs J; Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven Belgium., Garrett DO; Sabin Vaccine Institute, Washington, DC, USA., Andrews JR; Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA, USA., Poudyal N; International Vaccine Institute, Seoul, South Korea., Kim DR; International Vaccine Institute, Seoul, South Korea., Clemens JD; International Vaccine Institute, Seoul, South Korea; Jonathan and Karin Fielding School of Public Health, University of California Los Angeles, Los Angeles, CA, USA., Baker SG; Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK., Kim JH; International Vaccine Institute, Seoul, South Korea; Department of Life Sciences, College of Natural Sciences, Seoul National University, Seoul, South Korea., Dougan G; Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK., Sugimoto JD; International Vaccine Institute, Seoul, South Korea; Epidemiologic Research and Information Center, Cooperative Studies Program, Office of Research and Development, United States Department of Veterans Affairs, Seattle, WA, USA; Department of Epidemiology, University of Washington, Seattle, WA, USA; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle WA USA., Van Puyvelde S; Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK; Laboratory of Medical Microbiology, Vaccine & Infectious Disease Institute, University of Antwerp, Antwerpen, Belgium., Kehinde A; Department of Medical Microbiology and Parasitology, College of Medicine, University of Ibadan, Ibadan, Nigeria., Popoola OA; Department of Community Medicine, University College Hospital, Ibadan, Nigeria; Department of Community Medicine, College of Medicine, University of Ibadan, Ibadan, Nigeria., Mogasale V; International Vaccine Institute, Seoul, South Korea., Breiman RF; Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA; Infectious Diseases and Oncology Research Institute, University of the Witwatersrand, Johannesburg, South Africa., MacWright WR; Public Health Surveillance Group, Princeton, NJ, USA., Aseffa A; Armauer Hansen Research Institute, Addis Ababa, Ethiopia., Tadesse BT; International Vaccine Institute, Seoul, South Korea; Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden; Center for Innovative Drug Development and Therapeutic Trials for Africa, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia., Haselbeck A; International Vaccine Institute, Seoul, South Korea., Adu-Sarkodie Y; School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana; Department of Clinical Microbiology, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana., Teferi M; Armauer Hansen Research Institute, Addis Ababa, Ethiopia., Bassiahi AS; Institut Supérieur des Sciences de la Population, Ouagadougou, Burkina Faso., Okeke IN; Department of Pharmaceutical Microbiology, Faculty of Pharmacy, University of Ibadan, Ibadan, Nigeria., Lunguya-Metila O; Department of Microbiology, Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo; Department of Medical Biology, Microbiology Service, University Teaching Hospital of Kinshasa, University of Kinshasa, Kinshasa, Democratic Republic of the Congo., Owusu-Dabo E; School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana., Rakotozandrindrainy R; Madagascar Institute for Vaccine Research, University of Antananarivo, Antananarivo, Madagascar.

Publikováno v: The Lancet. Global health [Lancet Glob Health] 2024 Apr; Vol. 12 (4), pp. e599-e610.